News

Under the terms of this agreement, Dendritic Nanotechnologies will build chemistries on proprietary Lumera surfaces, focusing efforts on using their expertise and patent holdings in the area of

The grant will be paid over two years and will support CollaGenex’s manufacturing and formulation development of incyclinide as well as preclinical studies that should advance the company’s

The phase I trial is designed to characterize the pharmacokinetic profile of two currently marketed drugs, identified by Stem Cell Therapeutics (SCT) as effective in non-clinical models of

The trial will recruit 50 patients with resected stage II or III melanoma who will be randomized to receive either Uvidem alone or Uvidem combined with peginterferon alpha-2b,

These data demonstrate the potential utility of INGN 241 in combination with Celebrex, a drug approved for the treatment of precancerous lesions of the colon, and exemplify the

These studies, undertaken by the MultiCell Technologies subsidiary, will seek to build on the success that the toll receptor molecule, MCT-465, demonstrated in previous preclinical studies of the

An aurora kinase inhibitor, CYC116, is a small molecule investigational drug, which has previously demonstrated anticancer activity after oral administration in both hematological and solid tumor models. The

Daily sub-cutaneous or intraperitoneal administration of CTCE-9908 was shown to prevent the spread of cancer to distant organs on average by 61%, providing positive preclinical results for CTCE-9908

Traditional flu-vaccine development involves the process of viral amplification in chicken eggs, followed by a lengthy process of inactivation, sterilization, and packaging. This method is very time consuming